Výsledky vyhledávání - "L Iu, Andreeva"

[Use of Mabtera (rituximab) in treating patients with refractory courses of B-cell lymphoma, along with high-dose chemotherapy and autologous transplantation of hematopoietic stem cells]

Autor: V V, Ptushkin, K L, Chimishkian, N V, Zhukov, D Sh, Osmanov, L Iu, Andreeva, N N, Tupitsyn, V B, Larionova, D M, Mkheidze, N V, Poddubnaia

Publikováno v: Terapevticheskii arkhiv. 75(1)

To study efficacy of rituximab in patients with resistant B-cell lymphoma on high-dose chemotherapy.From September 2000 to April 2002 we studied efficacy and tolerance of rituximab at different stages of high-dose chemotherapy. The treatment was give

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b33465681f190bba922e33c46b98db07
https://pubmed.ncbi.nlm.nih.gov/12652962

Zobrazit plný text záznamu

[Use of subgrafting doses of peripheral stem cells is a new approach to overcoming hematological toxicity of multiple intensive courses of chemotherapy in children]

Autor: M Ia, Iankelevich, I S, Dolgopolov, L Iu, Andreeva, R S, Ravshanova, D G, Izhogin, D M, Mkheidze, E V, Ogorodnikova, G L, Mentkevich

Publikováno v: Vestnik Rossiiskoi akademii meditsinskikh nauk. (6)

The authors examined 8 patients with pretreated relapsing or resistant solid tumors (Wilms'--4, rhabdomyosarcoma--3, synovial sarcoma--1) who received 16 courses of chemotherapy: iphosphamide, 1800 mg/m2/day (days 1-5), vepeside, 100 mg/m2/day (days

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a8e94a533c593e03fc9709d94e912ccf
https://pubmed.ncbi.nlm.nih.gov/10943156

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání